Study of SyB L-0501 to Treat Relapsed/Refractory Multiple Myeloma
Clinical trial NCT01849848 · COMPLETED
Trial details
- NCT number
- NCT01849848
- Sponsor
- SymBio Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-07-01
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.